From Yahoo Finance: 2025-06-06 17:15:00

Veeva Systems Inc. (VEEV) has seen strong performance in Q1 FY2026, with revenue reaching $759 million, surpassing estimates by 4.3%. Subscription services grew 18.9% to $634.8 million, while professional services rose 6.8%. Gross margin improved to 79.2%, but non-GAAP operating margin declined to 30.8% due to higher investments. EPS of $1.97 beat expectations by 13.2%.

Veeva achieved its $3 billion annual revenue run rate ahead of schedule, driven by growth in Crossix and Vault CRM. Over 80 customers are live on Vault CRM, with plans to reach 200 by FY2027. Four top 20 pharma firms have committed to the platform, highlighting its integration of sales, marketing, and medical functions. Clinical products are gaining traction, with 19 of the top 20 pharma companies using eTMF and nine adopting EDC. Development Cloud is expected to grow 19% in FY2026, supported by cross-sell momentum.

AI is key to Veeva’s strategy, with embedded agents across CRM, safety, and regulatory functions promising industry efficiency gains by 2030. Customer sentiment remains positive, supported by a robust product roadmap. Veeva raised its FY2026 guidance, reflecting strong execution and growing demand across verticals. The stock is up 20.4% as of 30th May.

Veeva Systems Inc. (VEEV) is not among the 30 Most Popular Stocks Among Hedge Funds. 55 hedge fund portfolios held VEEV at the end of the first quarter, down from 60 in the previous quarter. While VEEV has potential as an investment, some AI stocks may offer greater promise for higher returns with limited downside risk. If you seek an extremely cheap AI stock benefiting from Trump tariffs and onshoring, check our free report on the best short-term AI stock.



Read more at Yahoo Finance: Veeva Systems Inc. (VEEV): A Bull Case Theory